| Test Name: |
SureSwab Advanced Vaginitis Plus, TMA |
| Test Code: |
2193894 |
| Alias: |
LAB15178
|
| CPT Code(s): |
81513
87481 x 2
87661
87491
87591
|
| Test Includes: |
SureSwab® Advanced Bacterial Vaginosis (BV), TMA
SureSwab® Advanced Candida Vaginitis (CV), TMA
Trichomonas vaginalis (TV), TMA
Chlamydia/Neisseria gonorrhoeae RNA, TMA, Urogenital |
| Preferred Specimen: |
1 vaginal swab |
| Container: |
Aptima® Multitest Transport Tube (orange label) |
| Collection Instructions: |
Follow instructions in the Aptima Multitest Collection Kit (orange label) |
| Transport Temperature: |
Room temperature |
| Stability: |
Room temperature: 30 days
Refrigerated: 30 days
Frozen: 60 days |
| Rejection Criteria: |
Transport tube with no swab • Transport tube with 2 swabs • Transport tube containing cleaning swab • Transport tube with non-Aptima swabs • Transport tube submitted with swab inverted • Swab submitted in viral transport media • Specimens with excess mucus • Specimens submitted in Aptima tubes with pierced foil lids |
| Schedule: |
Set up: Mon, Wed-Sat; Report available: 5-6 days |
| Method: |
Transcription Mediated Amplification (TMA) |
| Performing Lab: |
Quest Diagnostics-Schaumburg: 10120 |
| Clinical Significance: |
SureSwab® Advanced Vaginitis Plus, TMA - The assay is intended to aid in the diagnosis of vaginitis using clinician-collected and patient-collected vaginal swab specimens from individuals with a clinical presentation consistent with vaginitis. Testing for bacterial vaginosis (BV), vulvovaginal candidiasis and trichomoniasis, as well as Chlamydia trachomatis and Neisseria gonorrhoeae is included.
The BV test is an in vitro nucleic acid amplification test that utilizes real time transcription-mediated amplification (TMA) for detection and quantitation of ribosomal RNA from bacteria associated with bacterial vaginosis (BV), including Lactobacillus (L. gasseri, L.crispatus, and L. jensenii), Gardnerella vaginalis, and Atopobium vaginae. The assay reports a qualitative result for BV and does not report results for individual organisms.
For vulvovaginal candidiasis and trichomoniasis, a real time transcription-mediated amplification (TMA) assay is used to detect and qualitatively report results for Candida species group (C. albicans, C. tropicalis, C. parapsilosis, C. dubliniensis, C. glabrata), and Trichomonas vaginalis.
For Chlamydia trachomatis and Neisseria gonorrhoeae, A target capture assay for the in vitro qualitative detection and differentiation of ribosomal RNA (rRNA) from Chlamydia trachomatis and/or Neisseria gonorrhoeae is utilized. |
| Use: |
Updated 09/13/2022 |
| Reference Ranges: |
SureSwab® Adv Bacterial Vaginosis (BV), TMA: Negative
Candida species: Not detected
Candida glabrata: Not detected
Trichomonas vaginalis (TV), TMA: Not detected
C. trachomatis RNA, TMA, Urogenital: Not detected N. gonorrhoeae RNA, TMA, Urogenital: Not detected |
|
The CPT codes included in this publication are in accordance with Current Procedural Terminology, a publication of the American Medical Association. CPT codes are provided here for the convenience of our clients; however, correct coding often varies from one carrier to another, and HealthLab may bill specific carriers using codes other than those shown. Clients who bill for services should verify the code(s) with the applicable payor to confirm that their use is appropriate in each case.
|
| Test Type: |
|